Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Smells like a conflict of interest to me.

<< Previous

Bullboard Posts

Next >>

Post by BlueJays9293on Jul 11, 2024 8:18pm

274 Views

Post# 36129445

Smells like a conflict of interest to me.

Price Waterhouse was just voted by shareholders to be reappointed as auditor at the June 7th annual meeting.

If a change was afoot, wouldn't it have happened then?

I wish I knew what changed in the last month.

Oh and Price Waterhouse is also Baxters auditor according to their last 10-K,

and I assume they will be Vantive's auditor as well.

Not to go too far down the rabbit hole,

But if you were Carlyle Group,

about to commit to 4 Billion dollars,

wouldn't you want to be absolutley darn sure,

that you would be able to obtain the other half of PMX?

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project